Trial Details

COMPLETED
Basic Information
Clinical ID c1039
Identifier NCT04877990
Trial Title A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn Disease|Ulcerative Colitis
Interventions DRUG: Deucravacitinib
Participant Information
Sponsor Bristol-Myers Squibb
City Shreveport
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2021-05-07
Primary Completion Date 2023-08-29
Completion Date 2023-08-29